Key Events This Week
May 21: Q4 FY26 results reveal profit surge but highlight operational crisis
May 22: Flat quarterly performance amid margin pressures reported
Week Close: Stock ends at Rs.26.19, down 9.72% for the week
Jun 29, 04:01 PM
BSE+NSE Vol: 14.04 k

Medi Caps Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 Feb 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 18 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Medi Caps Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 Feb 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 27 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read full news article
May 21: Q4 FY26 results reveal profit surge but highlight operational crisis
May 22: Flat quarterly performance amid margin pressures reported
Week Close: Stock ends at Rs.26.19, down 9.72% for the week
Medi Caps Ltd's latest financial results for Q4 FY26 present a complex picture that warrants careful analysis. The company reported a net profit of ₹3.04 crores, which reflects a significant year-on-year increase of 76.74%. However, this profit was largely driven by exceptional other income amounting to ₹5.59 crores, which constituted a substantial portion of the profit before tax. Without this non-recurring income, the company would have faced an operational loss of ₹2.06 crores, indicating serious underlying challenges in its core business operations. In terms of revenue, Medi Caps experienced a sharp decline, with reported sales of ₹3.45 crores, representing a 50.50% decrease year-on-year and a 19.77% decline quarter-on-quarter. This trend of revenue contraction highlights significant operational distress, as the company has struggled to maintain consistent sales levels, with sequential revenues showing...
Read full news article
Medi Caps Ltd reported a flat financial performance for the quarter ended March 2026, marking a notable improvement from the previous negative trend. Despite a significant contraction in net sales and operating profitability, the company achieved its highest quarterly PAT and EPS to date, signalling a tentative stabilisation in earnings amid ongoing challenges in the pharmaceuticals sector.
Read full news article
Medi Caps Ltd., India's second-largest manufacturer of empty hard gelatine capsules, reported a net profit of ₹3.04 crores for Q4 FY26, marking a dramatic 76.74% year-on-year increase from ₹1.72 crores in Q4 FY25. However, this apparent profitability triumph conceals a troubling reality: the company's core operations continue to deteriorate, with revenues collapsing 50.50% year-on-year to just ₹3.45 crores, whilst operating losses deepened alarmingly. The stock has reacted negatively to the broader operational distress, declining 1.41% following the results announcement.
Read full news articleThe next results date for Medi Caps Ltd is scheduled for 21 May 2026....
Read full news article
Medi Caps Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 Feb 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 12 May 2026, providing investors with the latest insights into its performance and outlook.
Read full news article
Medi Caps Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 Feb 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and overall market stance.
Read full news articleThe Trading window shall remain closed for the trading of the share of the company form 1st July 2026 till the completion of 48 hours of declaration of un-audited financial results for the quarter ended on 30.06.2026
Please find enclosed intimation regarding resignation of Chief Financial Officer.
Standalone and consolidated audited financial results for the quarter and year ended 31.03.2026 approved by the Board in their 01/2026-27 Board meeting held on 21.05.2026.An extract of the same published in Free Press Journal English edition and Choutha Sansar Hindi edition on 23.05.2026. Copy of the same being enclosed.
No Upcoming Board Meetings
Medi Caps Ltd has declared 15% dividend, ex-date: 20 Sep 12
No Splits history available
Medi Caps Ltd has announced 3:1 bonus issue, ex-date: 19 Mar 13
No Rights history available